Checkpoint blockade immunotherapy enhances the frequency and effector function of murine tumor-infiltrating T cells but does not alter TCRβ diversity

Kuehm LM1, Wolf K1, Zahour J1, DiPaolo RJ1,2, Teague RM3,4; 1 Molecular Microbiology and Immunology Department, Saint Louis University School of Medicine, 1100 South Grand Blvd, St. Louis, MO, 63104, USA. 2 Alvin J. Siteman National Cancer Institute Comprehensive Cancer Center, St. Louis, MO, USA. 3 Molecular Microbiology and Immunology Department, Saint Louis University School of Medicine, 1100 South Grand Blvd, St. Louis, MO, 63104, USA. ryan.teague@health.slu.edu. 4 Alvin J. Siteman National Cancer Institute Comprehensive Cancer Center, St. Louis, MO, USA. ryan.teague@health.slu.edu.